• Biopsy, Mediastinal Lymph Node
  • Cystatin C, Serum
  • Neisseria gonorrhoeae Nucleic Acid, Liquid Cytology
  • Alpha Thalassemia Genetic Testing
  • Neuroblastoma
  • TGFBR1 Gene Mutation Analysis
  • Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
  • MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • Potassium, 24 Hour, Urine
  • Atypical Pneumonia DNA Panel, Bronchial Wash/Lavage
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Additional ICD10
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.